The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension
Crossref DOI link: https://doi.org/10.1007/s11845-017-1580-5
Published Online: 2017-02-21
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buda, V.
Andor, M.
Cristescu, C.
Voicu, M.
Cochera, F.
Tuduce, P.
Petrescu, L.
Tomescu, M. C.
Funding for this research was provided by:
"Victor Babes" University of Medicine and Pharmacy (PII-C4-TC-2016/16441-09)
License valid from 2017-02-21